BETA DRUGS LIMITED (BETA)

NSE: ₹1,471.70
Back to Home
Stock Performance
Corporate Announcements
No recent announcements available.

Quarterly Financials

Consolidated Standalone
Particulars Mar 2025 Sep 2025 Dec 2025 Mar 2026
Revenue from Operations 182.05 203.59 87.27 93.96
YOY Revenue Growth % - - - -
Other Income 4.93 5.98 2.31 2.89
Total Income 186.98 209.57 89.58 96.86
Total Expenses + 158.22 177.48 79.11 85.03
Cost of Materials Consumed 87.96 104.53 32.50 36.78
Employee Benefit Expense 17.68 19.23 16.82 18.68
Other Expenses 42.33 44.31 17.42 21.51
Operating Profit 23.83 26.11 8.16 8.94
OPM % 13.1% 12.8% 9.4% 9.5%
Profit Before Tax + 24.19 32.09 10.47 11.83
Tax Expense 24.19 32.09 1.95 2.78
Tax % 100% 100% 18.7% 23.5%
Profit After Tax 0.00 0.00 8.52 9.05
EPS (Basic) 17.81 47.38 8.40 8.93

Yearly Financial Results

Consolidated Standalone
No yearly financial data available for Consolidated.